These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 17974958

  • 1. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
    Iwata C, Kano MR, Komuro A, Oka M, Kiyono K, Johansson E, Morishita Y, Yashiro M, Hirakawa K, Kaminishi M, Miyazono K.
    Cancer Res; 2007 Nov 01; 67(21):10181-9. PubMed ID: 17974958
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C.
    Liu H, Yang Y, Xiao J, Lv Y, Liu Y, Yang H, Zhao L.
    Anat Rec (Hoboken); 2009 Oct 01; 292(10):1577-83. PubMed ID: 19685508
    [Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
    Di JM, Zhou J, Zhou XL, Gao X, Shao CQ, Pang J, Sun QP, Zhang Y, Ruan XX.
    Arch Med Res; 2009 May 01; 40(4):268-75. PubMed ID: 19608016
    [Abstract] [Full Text] [Related]

  • 4. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.
    Liu H, Yang Y, Xiao J, Lv Y, Liu Y, Yang H, Zhao L.
    Anat Rec (Hoboken); 2010 Nov 01; 293(11):1838-46. PubMed ID: 20830783
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
    Morita Y, Hata K, Nakanishi M, Nishisho T, Yura Y, Yoneda T.
    Int J Oncol; 2012 Sep 01; 41(3):885-92. PubMed ID: 22735610
    [Abstract] [Full Text] [Related]

  • 6. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO.
    Cancer Res; 2005 Nov 01; 65(21):9789-98. PubMed ID: 16267000
    [Abstract] [Full Text] [Related]

  • 7. [COX- 2 expression in gastric cancer and its relationship with lymphangiogenesis and lymph node metastasis].
    Zhang J, Ji J, Yuan F, Yan C, Yu YY, Liu BY, Zhu ZG, Yin HR, Lin YZ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jul 01; 8(4):348-51. PubMed ID: 16167260
    [Abstract] [Full Text] [Related]

  • 8. [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].
    Wang KF, Ye SL, Song LJ, Weng YQ, Liang CM, Zhao Y, Gao DM, Tang ZY.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar 01; 14(3):187-91. PubMed ID: 16556412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
    Yanai Y, Furuhata T, Kimura Y, Yamaguchi K, Yasoshima T, Mitaka T, Mochizuki Y, Hirata K.
    J Exp Clin Cancer Res; 2001 Sep 01; 20(3):419-28. PubMed ID: 11718224
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
    Kawakami M, Yanai Y, Hata F, Hirata K.
    Surg Today; 2005 Sep 01; 35(2):131-8. PubMed ID: 15674494
    [Abstract] [Full Text] [Related]

  • 12. Molecular control of lymphatic metastasis.
    Achen MG, Stacker SA.
    Ann N Y Acad Sci; 2008 Sep 01; 1131():225-34. PubMed ID: 18519975
    [Abstract] [Full Text] [Related]

  • 13. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
    Zhang D, Li B, Shi J, Zhao L, Zhang X, Wang C, Hou S, Qian W, Kou G, Wang H, Guo Y.
    Cancer Res; 2010 Mar 15; 70(6):2495-503. PubMed ID: 20197464
    [Abstract] [Full Text] [Related]

  • 14. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
    Sipos B, Kojima M, Tiemann K, Klapper W, Kruse ML, Kalthoff H, Schniewind B, Tepel J, Weich H, Kerjaschki D, Klöppel G.
    J Pathol; 2005 Nov 15; 207(3):301-12. PubMed ID: 16161179
    [Abstract] [Full Text] [Related]

  • 15. Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer.
    Da MX, Wu XT, Wang J, Guo TK, Zhao ZG, Luo T, Zhang MM, Qian K.
    Arch Med Res; 2008 Jan 15; 39(1):92-9. PubMed ID: 18068001
    [Abstract] [Full Text] [Related]

  • 16. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T, Katsumata K, Tsuchida A, Wada T, Mori Y, Hisada M, Kawakita H, Aoki T.
    Int J Mol Med; 2006 Feb 15; 17(2):357-62. PubMed ID: 16391837
    [Abstract] [Full Text] [Related]

  • 17. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B, Zhang Y, Luo G, Li L, Zhang J.
    Anat Rec (Hoboken); 2009 May 15; 292(5):633-9. PubMed ID: 19382240
    [Abstract] [Full Text] [Related]

  • 18. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
    Liu H, Xiao J, Yang Y, Liu Y, Ma R, Li Y, Deng F, Zhang Y.
    Microvasc Res; 2011 Sep 15; 82(2):131-40. PubMed ID: 21600223
    [Abstract] [Full Text] [Related]

  • 19. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
    He XW, Yu X, Liu T, Yu SY, Chen DJ.
    Chin Med J (Engl); 2008 Mar 05; 121(5):439-44. PubMed ID: 18364118
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
    Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK.
    Cancer Res; 2005 Oct 01; 65(19):9004-11. PubMed ID: 16204074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.